Confined or spread disease-Spread with distant metastasis Page 2 Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread with distant metastasis Posts on Medivizor

Is regorafenib a safe option for the treatment of metastatic colorectal cancer?

Posted by on Nov 22, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of regorafenib (Stivarga) to treat patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC) that progressed after initial treatment. Researchers suggested that regorafenib is a safe option to treat these patients. Some background The standard treatment...

Read More

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Posted by on Nov 11, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to see how well two medications worked in treating advanced triple negative breast cancer, atezolizumab (Tecentriq) and nab-paclitaxcel (Abraxane).  The study found that using these two medications together improved survival in these patients. Some background Triple-negative breast cancer (TNBC) is breast cancer...

Read More

Metronomic chemotherapy for HR+ advanced breast cancer

Posted by on Nov 7, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to see how well using metronomic chemotherapy with capecitabine (Xeloda) combined with aromatase inhibitors works for patients with hormone receptor positive advanced breast cancer. The study found that this treatment works well and is safe, and therefore should be considered as a potential treatment option. Some...

Read More

TVEC as a treatment for advanced melanoma

Posted by on Oct 26, 2018 in Melanoma | 0 comments

In a nutshell This study analysed a treatment for late-stage melanoma called talimogene laherparepvec (TVEC). It found that treating late-stage melanoma with TVEC was effective, and had only minor side effects. Some background Talimogene laherparepvec (TVEC) (Imlygic) is a treatment used for late-stage melanoma which is unable to be operated on. TVEC...

Read More

Surgery to remove the main tumor in patients with breast cancer that has spread

Posted by on Oct 18, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if removing the main tumor in women with cancer that has spread to other organs leads to greater survival than not removing the main tumor. The study found that the patients who had the surgery survived 47% longer than patients without the surgery. Some background Breast cancer can sometimes be caught quite...

Read More

Local treatment in metastatic colorectal cancer is a safe option for the elderly and for patients with other medical conditions

Posted by on Oct 13, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether local ablative methods (LAT; non-invasive procedures) of treatment can be used in patients with colorectal cancer that are older or have other medical conditions. Researchers suggested that these procedures may be performed safely in these patients. Some background Age is a major risk factor for colorectal...

Read More

Effect of cancer medications nivolumab and ipilimumab on melanoma which has spread to the brain

Posted by on Sep 15, 2018 in Melanoma | 0 comments

In a nutshell This study looked at two medications for treatment of melanoma, nivolumab (Opdivo) and ipilimumab (Yervoy), and analysed how well they worked in patients who have melanoma which has spread to the brain. The study found that the combination of nivolumab and ipilimumab had significant clinical benefit in patients with melanoma with brain...

Read More

Fulvestrant compared to aromatase inhibitors in post-menopausal women with HR+ advanced breast cancer

Posted by on Jul 16, 2018 in Breast cancer | 0 comments

In a nutshell This study aimed to look at the safety and effectiveness of fulvestrant (Faslodex) compared to aromatase inhibitors in post-menopausal women with hormone receptor-positive (HR+) breast cancer. The authors found that fulvestrant was a safe and effective treatment in these patients when compared to aromatase inhibitors. Some...

Read More

Vitamin D is associated with melanoma outcomes

Posted by on May 6, 2018 in Melanoma | 0 comments

In a nutshell This study investigated if low levels of vitamin D are associated with worse melanoma prognosis. Researchers suggested that low levels of vitamin D are associated with worse outcomes in metastatic (spread to other parts of the body) melanoma. Some background Recent studies have suggested that a low vitamin D level (less than 20...

Read More

Vemurafenib combined with cobimetinib is an effective treatment option for advanced melanoma

Posted by on Jan 7, 2018 in Melanoma | 0 comments

In a nutshell This study examined the effectiveness of treatment with vemurafenib (Zelboraf) and cobimetinib (Cotellic) in metastatic (spread to other parts of the body) melanoma. Researchers suggested that this combination improves treatment outcomes. Some background PD-L1 is a protein present in the immune system that helps attacking cancer...

Read More